Patent application number | Description | Published |
20100070331 | ARCHITECTURAL DESIGN FOR SERVICE REQUEST AND ORDER MANAGEMENT APPLICATION SOFTWARE - Methods, systems, and apparatus, including computer program products, for implementing a software architecture design for a software application implementing service request and order management. The application is structured as multiple process components interacting with each other through service interfaces, and multiple service operations, each being implemented for a respective process component. The process components include an Outbound Delivery process component, a Site Logistics Processing process component, an Inventory Processing process component, a Customer Requirement Processing process component, a Supply and Demand Matching process component, a Logistics Execution Control process component, a Service Request Processing process component, a Service Order Processing process component, and a Service Confirmation Processing process component. | 03-18-2010 |
20100070336 | Providing Customer Relationship Management Application as Enterprise Services - Methods and apparatus, including systems and computer program products, for a services architecture design that provides enterprise services having customer relationship management functionality at the level of an enterprise application. The design includes a set of service operations, process components, and optionally deployment units. Suitable business objects are also described. | 03-18-2010 |
20100070556 | Architectural Design for Data Migration Application Software - Methods, systems, and apparatus, including computer program products, for implementing a software architecture design for a software application implementing data migration. The application is structured as multiple process components interacting with each other through service interfaces, and multiple service operations, each being implemented for a respective process component. The process components include a Product Property Management process component, a Production Model Management process component, a Business Partner Data Management process component, a Product Data Maintenance process component, an Installed Base Data Management process component, a Price Master Data Management process component, an Identity Management process component, an Engineering Change Processing process component, a Migration Data Dispatching process component, and several other process components. | 03-18-2010 |
Patent application number | Description | Published |
20090256584 | GAP INSPECTION APPARATUS - An apparatus for inspection of a gap between two surfaces, at least one of which is ferromagnetic, for example in a generator, includes a sensor platform ( | 10-15-2009 |
20090266700 | SWITCH FOR A BRUSH WEAR RECORDING CIRCUIT - A switch for a brush wear monitoring recording circuit for monitoring wear of at least one brush, the switch having an open and a closed state, comprises a fixed part including a switch plate having a switch face and a moving part including a capacitive flag disposed on a brush so as to move the capacitive flag corresponding to a brush wear movement in a brush wear direction and a capacitive plate having a capacitive face, wherein the capacitive face and the switch face are disposed parallel to each other and provide capacitance to the switch, and further wherein the capacitive flag is disposed on the brush so as to bring the capacitive face and the switch face in proximity to each other so as to face each other and increase capacitance, thereby changing the switch state. | 10-29-2009 |
20090267444 | SWITCH FOR A BRUSH WEAR RECORDING CIRCUIT - A switch for a recording circuit used to determine brush wear of an electrical brush comprises a flag having a first end and a second end defining distal ends of the flag. The flag is mounted on the electrical brush at the first end so as to move in unison with brush wear while being in electrical communication with the electrical brush and has a piercing feature on the second end. The switch further comprises a contact plate arrange relative to the flag so as to bring the flag in contact with the contact plate at a predetermined brush wear and includes an inner conductive core encased by a cover forming an outer layer of the contact plate, wherein the piercing feature is configured to penetrate the cover and to contact the conductive core to cause electrically continuous contact between the flag and the contact plate and close the switch. | 10-29-2009 |
20090267782 | BRUSH WEAR MONITOR - A worn brush monitoring system for monitoring a plurality of brushes of an electrical machine comprises a plurality of mounted flags configured to be in moveable communication relative to a wear of each of the plurality of brushes and an electrical recording circuit. The electrical recording circuit includes at least one impedance device configured to provide impedance data, at least one switch having a contact plate interactable with at least two of the plurality of mounted flags at different points along a length of the contact plate and an impedance dependent on the length of the contact plate, and a recording device configured to detect changes in electrical characteristics in the electrical recording circuit resulting from changes in a switch state, the switch state defined by the interaction between the mounted flags and the electrical recording circuit, as a result of brush wear. | 10-29-2009 |
20110084671 | METHOD FOR MONITORING AN ELECTRODYNAMIC MACHINE - A method for monitoring an electrodynamic machine a stator and a rotor arrangement mounted along a rotatable shaft. The rotor arrangement is disposed within the stator and forms an air gap between the rotor arrangement and the stator. At least one sensor is disposed in the air gap and/or within the stator. Measurement signals are detected that are dependent on a magnetic field produced by the electrodynamic machine. The measurement signals are used as a basis for detecting oscillations of the shaft. | 04-14-2011 |
20110234181 | DEVICE AND METHOD FOR MONITORING AND/OR ANALYZING ROTORS OF ELECTRIC MACHINES IN OPERATION - A method is provided for monitoring and/or analysis of electrical machines during operation. An electrical machine has at least one generator with a shaft, an exciter system and drive device that drives the shaft. In this case, a first signal, which describes a voltage across a rotor winding, and a second signal, which describes a current flowing through the rotor winding, are measured simultaneously. The two signals are supplied to an analysis unit. The signals are split into individual frequency components in the analysis unit. The impedance of the rotor winding is then determined in order to identify fault states in the electrical machine. | 09-29-2011 |
Patent application number | Description | Published |
20110237532 | 1-[(3-CYANO-PYRIDIN-2-YL)METHYL]-3-METHYL-7-(2-BUTYN-1-YL)-8-[3-(R)-AMINO-- PIPERIDIN-1-YL]-XANTHINE FOR THE TREATMENT OF A METABOLIC DISORDER OF A PREDOMINANTLY CARNIVOROUS NON-HUMAN ANIMAL - The present invention provides a pharmaceutical composition comprising 1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(R)-amino-piperidin-1-yl]-xanthine or a pharmaceutically acceptable form thereof as pharmaceutically active compound for the therapy of a metabolic disorder or metabolic disease of a predominantly carnivorous non-human animal. It is especially useful for the therapy of diabetes and related diseases of predominantly carnivorous mammals like cats or dogs. The invention further provides respective uses of such compositions and of 1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(R)-amino-piperidin-1-yl]-xanthine or pharmaceutically acceptable forms thereof. | 09-29-2011 |
20120035158 | Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions - The present invention relates to substituted xanthines of general formula | 02-09-2012 |
20120040982 | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions - The present invention relates to substituted xanthines of general formula | 02-16-2012 |
20120121530 | Vasoprotective and cardioprotective antidiabetic therapy - The present invention relates to certain DPP-4 inhibitors for treating and/or preventing oxidative stress, vascular stress and/or endothelial dysfunction as well as to the use of such DPP-4 inhibitors in treatment and/or prevention of diabetic or non-diabetic patients, including patient groups at risk of cardiovascular and/or renal disease. | 05-17-2012 |
20120165251 | Diabetes therapy - The present invention relates to methods for treating and/or preventing metabolic diseases comprising the combined administration of a DPP-4 inhibitor and a long-acting insulin. The invention further relates to a DPP-4 inhibitor for subcutaneous or transdermal use. | 06-28-2012 |
20120196812 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF - The invention relates to the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia using a SGLT-2 inhibitor. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions. | 08-02-2012 |
20120208831 | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions - The present invention relates to substituted xanthines of general formula | 08-16-2012 |
20120252782 | Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions - The present invention relates to substituted xanthines of general formula | 10-04-2012 |
20120252783 | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions - The present invention relates to substituted xanthines of general formula | 10-04-2012 |
20120283169 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF - The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor and an insulin which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions | 11-08-2012 |
20130035281 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF - The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor and a GLP-1 receptor agonist which is suitable in the treatment or prevention of diabetes mellitus, impaired glucose tolerance, hyperglycemia or other conditions. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions. | 02-07-2013 |
20130065792 | INDUCIBLE EXPRESSION OF SGLT5, METHODS AND KITS USING THE SAME - The present invention pertains to the function of SGLT5 as a sodium dependent co-transporter of mannose and/or fructose. The invention provides nucleic acids and host cells for inducible expression of SGLT5. Based on an inducible expression system the invention provides methods, assays and test kits for the identification of compounds interacting with SGLT5, especially with human SGLT5. | 03-14-2013 |
20130109703 | Combination of a GPR119 Agonist and the DPP-IV Inhibitor Linagliptin for Use in the Treatment of Diabetes and Related Conditions | 05-02-2013 |
20130165428 | XANTHINE DERIVATIVES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS - The present invention relates to substituted xanthines of general formula | 06-27-2013 |
20130172244 | SUBCUTANEOUS THERAPEUTIC USE OF DPP-4 INHIBITOR - The present invention relates to methods for treating and/or preventing metabolic diseases comprising the subcutaneous or transdermal administration of a therapeutically effective amount of a certain DPP-4 inhibitor. The invention further relates to a subcutaneous combination of a certain DPP-4 inhibitor and GLP-1 having a short half life, particularly for reducing weight. | 07-04-2013 |
20130196898 | TREATMENT OF GENOTYPED DIABETIC PATIENTS WITH DPP-IV INHIBITORS SUCH AS LINAGLIPTIN - The present invention relates to methods for preventing or treating of metabolic disorders and related conditions, such as in certain patient groups. | 08-01-2013 |
20130281373 | COMBINATION THERAPY - The present invention relates to methods for treating and/or preventing metabolic diseases comprising the combined administration of a GLP-1 receptor agonist and a DPP-4 inhibitor. | 10-24-2013 |
20130303462 | USE OF A DPP-4 INHIBITOR IN PODOCYTES RELATED DISORDERS AND/OR NEPHROTIC SYNDROME - The present invention relates to methods for treating and/or preventing podocytes related disorders and/or nephrotic syndrome comprising the administration of an effective amount of a certain DPP-4 inhibitor, as well as to the use of a certain DPP-4 inhibitor for treating and/or preventing a metabolic disease in a patient with or at risk of podocytes related disorders and/or nephrotic syndrome. | 11-14-2013 |
20130303554 | USE OF A DPP-4 INHIBITOR IN SIRS AND/OR SEPSIS - The present invention relates to methods for treating and/or preventing SIRS and/or sepsis comprising the administration of an effective amount of a certain DPP-4 inhibitor, as well as to the use of a certain DPP-4 inhibitor for treating and/or preventing a metabolic disease in a patient with or at risk of SIRS and/or sepsis. | 11-14-2013 |
20130310398 | Combination therapy for the treatment of diabetes and related conditions - Combinations of DPP-4 inhibitors with GPR119 agonists, as well as to the use of these combinations for treating and/or preventing metabolic diseases, particularly diabetes (especially type 2 diabetes mellitus) and conditions related thereto. | 11-21-2013 |
20130315975 | USE OF KERATINOCYTES AS A BIOLOGICALLY ACTIVE SUBSTANCE IN THE TREATMENT OF WOUNDS, SUCH AS DIABETIC WOUNDS, OPTIONALLY IN COMBINATION WITH A DPP-4 INHIBITOR - The invention relates to new keratinocytes which may be cultured in vitro and the use thereof for preparing a product which can be used to treat acute and chronic wounds, in combination with a DPP-4 inhibitor. | 11-28-2013 |
20130324463 | USE OF A DPP-4 INHIBITOR FOR MODIFYING FOOD INTAKE AND REGULATING FOOD PREFERENCE - The present invention relates to the use of a certain DPP-4 inhibitor for modifying food intake and regulating food preference. | 12-05-2013 |
20140031301 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF - The invention relates to the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia using a SGLT-2 inhibitor. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions. | 01-30-2014 |
20140038911 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF - The invention relates to a pharmaceutical composition according to the claim | 02-06-2014 |
20140057901 | XANTHINE DERIVATIVES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS - The present invention relates to substituted xanthines of general formula | 02-27-2014 |
20140087996 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF - The invention relates to a pharmaceutical composition according to the claim | 03-27-2014 |
20140088027 | PHARMACEUTICAL COMPOSITION COMPRISING AN SGLT2 INHIBITOR AND A PPAR- GAMMA AGONIST AND USES THEREOF - The invention relates to a pharmaceutical composition comprising an SGLT2 inhibitor and a PPARĪ³ agonist which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions. | 03-27-2014 |
20140128604 | 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS - The present invention relates to substituted xanthines of general formula | 05-08-2014 |
20140135348 | USES OF DPP IV INHIBITORS - The specification describes the use of selected DPP IV inhibitors for the treatment of physiological functional disorders and for reducing the risk of the occurrence of such functional disorders in at-risk patient groups. In addition, the use of the above-mentioned DPP IV inhibitors in conjunction with other active substances is described, by means of which improved treatment outcomes can be achieved. These applications may be used to prepare corresponding medicaments. | 05-15-2014 |
20140256624 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF - The invention relates to a pharmaceutical composition according to the claim | 09-11-2014 |
20140343014 | COMBINATION OF A CERTAIN DPP-4 INHIBITOR AND VOGLIBOSE - The present invention relates to the use of a combination of a certain DPP-4 inhibitor and an alpha-glucosidase inhibitor for use in therapy, e.g. for use in treating and/or preventing a metabolic disease such as type 2 diabetes mellitus and/or conditions related thereto. The invention also relates to the use of such combination for improving body weight control, reducing body weight, inducing satiety, inhibiting gastric emptying and/or reducing food intake, in a patient in need thereof. | 11-20-2014 |
20150196565 | VASOPROTECTIVE AND CARDIOPROTECTIVE ANTIDIABETIC THERAPY - The present invention relates to certain DPP-4 inhibitors for treating and/or preventing oxidative stress, vascular stress and/or endothelial dysfunction as well as to the use of such DPP-4 inhibitors in treatment and/or prevention of diabetic or non-diabetic patients, including patient groups at risk of cardiovascular and/or renal disease. | 07-16-2015 |
20150291627 | 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS - The present invention relates to substituted xanthines of general formula | 10-15-2015 |
20160000798 | USES OF DPP IV INHIBITORS - The specification describes the use of selected DPP IV inhibitors for the treatment of physiological functional disorders and for reducing the risk of the occurrence of such functional disorders in at-risk patient groups. In addition, the use of the above-mentioned DPP IV inhibitors in conjunction with other active substances is described, by means of which improved treatment outcomes can be achieved. These applications may be used to prepare corresponding medicaments. | 01-07-2016 |
20160038500 | COMBINATION THERAPY - The present invention relates to methods for treating and/or preventing metabolic diseases comprising the combined administration of a GLP-1 receptor agonist and a DPP-4 inhibitor. | 02-11-2016 |
20160058769 | TREATMENT FOR DIABETES IN PATIENTS WITH INSUFFICIENT GLYCEMIC CONTROL DESPITE THERAPY WITH AN ORAL OR NON-ORAL ANTIDIABETIC DRUG - The present invention relates to the finding that certain DPP-4 inhibitors are particularly suitable for treating and/or preventing metabolic diseases, particularly diabetes, in patients with insufficient glycemic control despite a therapy with an oral and/or a non-oral antidiabetic drug. | 03-03-2016 |
20160082011 | USE OF A DPP-4 INHIBITOR IN PODOCYTES RELATED DISORDERS AND/OR NEPHROTIC SYNDROME - The present invention relates to methods for treating and/or preventing podocytes related disorders and/or nephrotic syndrome comprising the administration of an effective amount of a certain DPP- | 03-24-2016 |
20160136180 | PURIN DERIVATIVES FOR USE IN THE TREATMENT OF FAB-RELATED DISEASES - The invention is directed to the use of selected purine derivatives for the treatment of hyperproliferative diseases. | 05-19-2016 |